Elliott Sigal, M.D., Ph.D.
Executive Vice President, Chief Scientific Officer and President, R&D, Bristol-Myers Squibb
Dr. Sigal, age 61, has been our Chief Scientific Officer since October 2004 and an Executive Vice President since November 2006. Dr. Sigal joined Bristol-Myers Squibb in November 1997 as Vice President of the newly created department of Applied Genomics and since then has held positions of increasing responsibility in both discovery and development. Dr. Sigal is a member of the President’s Council of The J. David Gladstone Institutes and a member of the Biomedical Scientific Advisory Board of the Vanderbilt University Medical Center. Dr. Sigal is a Director of Mead Johnson Nutritional Company.